On May 13, Simcere Pharma (02096) spent 12.2958 million Hong Kong dollars to repurchase 1.063 million shares.
Sinopharm Healthcare (02096) announced that on May 13, 2026, it spent 12.2958 million Hong Kong dollars to repurchase 1.063 million shares.
Simcere Pharma (02096) announced on May 13, 2026 that it will spend 12.2958 million Hong Kong dollars to buy back 1.063 million shares.
Related Articles
On May 13, TRADEGO (08017) spent 2.52 million Hong Kong dollars to repurchase 2 million shares.
On May 13th, JXR (01951) spent 7.813 million Hong Kong dollars to repurchase 3.265 million shares.
New stock news | Feishit Technology applied for a second listing on the Hong Kong Stock Exchange.
On May 13, TRADEGO (08017) spent 2.52 million Hong Kong dollars to repurchase 2 million shares.
On May 13th, JXR (01951) spent 7.813 million Hong Kong dollars to repurchase 3.265 million shares.
New stock news | Feishit Technology applied for a second listing on the Hong Kong Stock Exchange.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
